Related Experiment Videos

[Symptomatic congenital complete atrioventricular block--a medical challenge]

G Hofstadler1, G Tulzer, K Schmitt

  • 1Department für pädiatrische Kardiologie, Landeskinderklinik Linz.

Klinische Padiatrie
|April 2, 1998
PubMed

Insights

Congenital complete atrioventricular block, associated with maternal antibodies, can be diagnosed via fetal echocardiography. Steroid therapy in the mother may prevent fetal hydrops, though a normal rhythm did not recur.

Area of Science:

  • Cardiology
  • Immunology
  • Obstetrics

Background:

  • Congenital complete atrioventricular block (CCAVB) is a rare condition.
  • It is frequently associated with maternal connective tissue disease and antibodies like anti-Ro (SS-A) and anti-La (SS-B).

Observation:

  • Diagnosis of CCAVB can be achieved through fetal Doppler-echocardiography as early as the 16th week of gestation.
  • In this case, CCAVB was diagnosed at 21 weeks gestation with ventricular and atrial rates of 55/min and 70/min, respectively.
  • Maternal anti-Ro and anti-La antibodies were detected, despite no overt signs of maternal connective tissue disease.

Findings:

  • Fetal hydrops was absent throughout the pregnancy, despite a continuous decrease in heart rate, reaching 28 bpm at term.
  • Maternal steroid therapy was administered from diagnosis until delivery.
  • No recurrence of normal cardiac rhythm was observed.

Implications:

  • Steroid therapy may play a role in preventing early fetal hydrops in cases of CCAVB.
  • Delivery should be considered upon the onset of fetal hydrops.
  • Permanent pacemaker implantation is preferred for symptomatic neonates with CCAVB.
  • Optimal management requires close collaboration between maternal and neonatal care teams.

Related Concept Videos